Literature DB >> 31659245

FOXP3 protects conventional human T cells from premature restimulation-induced cell death.

Kelsey Voss1, Camille Lake1, Christopher R Luthers1, Nathaniel M Lott2, Batsukh Dorjbal1, Swadhinya Arjunaraja1, Bradly M Bauman1, Anthony R Soltis2, Gauthaman Sukumar2, Clifton L Dalgard2,3, Andrew L Snow4.   

Abstract

The adaptive immune response relies on specific apoptotic programs to maintain homeostasis. Conventional effector T cell (Tcon) expansion is constrained by both forkhead box P3 (FOXP3)+-regulatory T cells (Tregs) and restimulation-induced cell death (RICD), a propriocidal apoptosis pathway triggered by repeated stimulation through the T-cell receptor (TCR). Constitutive FOXP3 expression protects Tregs from RICD by suppressing SLAM-associated protein (SAP), a key adaptor protein that amplifies TCR signaling strength. The role of transient FOXP3 induction in activated human CD4 and CD8 Tcons remains unresolved, but its expression is inversely correlated with acquired RICD sensitivity. Here, we describe a novel role for FOXP3 in protecting human Tcons from premature RICD during expansion. Unlike FOXP3-mediated protection from RICD in Tregs, FOXP3 protects Tcons through a distinct mechanism requiring de novo transcription that does not require SAP suppression. Transcriptome profiling and functional analyses of expanding Tcons revealed that FOXP3 enhances expression of the SLAM family receptor CD48, which in turn sustains basal autophagy and suppresses pro-apoptotic p53 signaling. Both CD48 and FOXP3 expression reduced p53 accumulation upon TCR restimulation. Furthermore, silencing FOXP3 expression or blocking CD48 decreased the mitochondrial membrane potential in expanding Tcons with a concomitant reduction in basal autophagy. Our findings suggest that FOXP3 governs a distinct transcriptional program in early-stage effector Tcons that maintains RICD resistance via CD48-dependent protective autophagy and p53 suppression.

Entities:  

Keywords:  CD48; FOXP3; RICD; autophagy; conventional T cells

Mesh:

Substances:

Year:  2019        PMID: 31659245      PMCID: PMC7852538          DOI: 10.1038/s41423-019-0316-z

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  57 in total

1.  Lineage relationship and protective immunity of memory CD8 T cell subsets.

Authors:  E John Wherry; Volker Teichgräber; Todd C Becker; David Masopust; Susan M Kaech; Rustom Antia; Ulrich H von Andrian; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-02-03       Impact factor: 25.606

2.  Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets.

Authors:  Andrew D Hislop; Umaimainthan Palendira; Alison M Leese; Peter D Arkwright; Pierre S Rohrlich; Stuart G Tangye; H Bobby Gaspar; Arjan C Lankester; Alessandro Moretta; Alan B Rickinson
Journal:  Blood       Date:  2010-07-19       Impact factor: 22.113

Review 3.  T-lymphocyte death during shutdown of an immune response.

Authors:  Andreas Strasser; Marc Pellegrini
Journal:  Trends Immunol       Date:  2004-11       Impact factor: 16.687

Review 4.  The power and the promise of restimulation-induced cell death in human immune diseases.

Authors:  Andrew L Snow; Pushpa Pandiyan; Lixin Zheng; Scott M Krummey; Michael J Lenardo
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

Review 5.  X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses.

Authors:  Hamid Bassiri; W C Janice Yeo; Jennifer Rothman; Gary A Koretzky; Kim E Nichols
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

6.  Qualitative and quantitative contributions of the T cell receptor zeta chain to mature T cell apoptosis.

Authors:  B Combadière; M Freedman; L Chen; E W Shores; P Love; M J Lenardo
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

7.  Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle.

Authors:  S A Boehme; M J Lenardo
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

8.  Activation-induced apoptosis of mature T cells is dependent upon the level of surface TCR but not on the presence of the CD3 zeta ITAM.

Authors:  J She; K Matsui; C Terhorst; S T Ju
Journal:  Int Immunol       Date:  1998-11       Impact factor: 4.823

9.  Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency.

Authors:  Andrew L Snow; Rebecca A Marsh; Scott M Krummey; Philip Roehrs; Lisa R Young; Kejian Zhang; Jack van Hoff; Deepali Dhar; Kim E Nichols; Alexandra H Filipovich; Helen C Su; Jack J Bleesing; Michael J Lenardo
Journal:  J Clin Invest       Date:  2009-09-14       Impact factor: 14.808

10.  Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis.

Authors:  M J Lenardo
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

View more
  4 in total

Review 1.  Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+ regulatory T cells.

Authors:  Mark D Mannie; Kayla B DeOca; Alexander G Bastian; Cody D Moorman
Journal:  Cell Immunol       Date:  2020-07-15       Impact factor: 4.868

2.  Restimulation-Induced Cell Death (RICD): Methods for Modeling, Investigating, and Quantifying RICD Sensitivity in Primary Human T Cells via Flow Cytometric Analysis.

Authors:  Katherine Pohida; Camille M Lake; Debra Yee; Andrew L Snow
Journal:  Bio Protoc       Date:  2022-02-20

Review 3.  Towards gene therapy for IPEX syndrome.

Authors:  Simon Borna; Esmond Lee; Yohei Sato; Rosa Bacchetta
Journal:  Eur J Immunol       Date:  2022-04-13       Impact factor: 6.688

Review 4.  IPEX as a Consequence of Alternatively Spliced FOXP3.

Authors:  Reiner K Mailer
Journal:  Front Pediatr       Date:  2020-10-21       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.